Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Must Reads by Date
Must reads for theWeek ending September 17, 2017
This Could Help Guide AML Treatment Decisions, JAMA Oncol; ePub 2017 Sep 7; Sorror, et al
Impact of Earlier Disease-Modifying Therapy, Leuk Res; 2017 Sep; Cogle, Reddy, Chang, et al
This Should Not Be a Barrier to Allogenic HSCT, Bone Marrow Transplant; ePub 2017 Sep 4; Modi, et al
Consolidation History Prognostic in These Patients, Am J Hematol; 2017 Oct; Rashidi, Linden, et al
Value of Day 14 Bone Marrow Evaluation Questioned, Am J Hematol; 2017 Oct; Terry, Shallis, et al
Must reads for theWeek ending September 10, 2017
Bone Marrow Features in Masked Polycythemia Vera, Am J Hematol; 2017 Oct; Kvasnicka, Orazi, et al
Which Patients with MF Are Splenectomy Candidates?, Am J Hematol; ePub 2017 Aug 24; Tefferi, et al
Hematologic Malignancies and Flu Risk Evaluated, J Med Virol; ePub 2017 Aug 29; Vilar-Compte, et al
Myeloid Neoplasm and Overlapping MDS/MPN Features, Leuk Lymphoma; ePub 2017 Aug 3; Thota, Gerds
Keys to TKI Success in Chronic Phase CML, Curr Hematol Malig Rep; ePub 2017 Aug 29; Tantravahi, et al
Must reads for theWeek ending September 3, 2017
Cochrane on Cancer Testing in People with VTE, Cochrane; 2017 Aug 23; Robertson, Yeoh, et al
Vitamin D Insufficiency and FL Outcomes, Blood Cancer J; ePub 2017 Aug 25; Tracy, et al
HCT Impact on Utilization in Sickle Cell Disease, Haematologica; ePub 2017 Aug 17; Arnold, et al
Impact of Fluid Overload on HSCT Outcomes, Biol Blood Marrow Transplant; ePub 2017 Aug 24; Rondón, et al
Does This Mutation Affect DLBCL Outcomes?, Biol Blood Marrow Transplant; ePub 2017 Aug 25; Lee, et al
Must reads for theWeek ending August 27, 2017
MF Treatment Pre- and Post Ruxolitinib Approval, Clin Lymphoma Myeloma Leuk; 2017 Aug 4; Kuykendall, et al
CML-BP Outcomes in Tyrosine Kinase Inhibitor Era , Cancer; ePub 2017 Jul 25; Jain, Kantarjian, et al
Predicting Survival in Patients with Post-PV/ET, Leukemia; ePub 2017 Aug 18; Tefferi, Saeed, et al
Ruxolitinib’s Role in Ph-Like ALL , Clin Adv Hematol Oncol; 2017 Jul; Wells, et al
Building on Ruxolitinib’s Success , Clin Lymphoma Myeloma Leuk; 2017 Jul; Bose, et al
Must reads for theWeek ending August 20, 2017
Guideline on HCT for Certain Lymphoma Types, Biol Blood Marrow Transplant; ePub 2017 Aug 7; Kharfan-Dabaja, et al
Weekend vs Weekday Leukemia Admissions, Clin Lymphoma Myeloma Leuk; ePub 2017 Aug 8; Parikh, et al
Health Care Use in People with AML at End of Life, J Clin Oncol; ePub 2017 Aug 7; Wang, Zeidan, et al
MCL in First Remission: Does Imaging Matter?, Leuk Lymphoma; ePub 2017 Aug 10; Guidot, et al
Cognitive Function After Allogeneic HCT Evaluated, Biol Blood Marrow Transplant; ePub 2017 Aug 7; Hoogland, et al
